Sanofi Names Belén Garijo as CEO, Signals Leadership Transition with Strategic Board Refresh
Sanofi's AGM appoints physician Belén Garijo as CEO effective May 1, 2026, approves €4.12 dividend and welcomes Orange's Heydemann to board.
SNYdividendcorporate governance